PCNA and neoplasm: Moreover, the subcutaneous tumor group of RORα-KO plus 3PO or RORα-KO plus DHEA revealed a reduction of Ki-67 and PCNA expression levels compared with RORα-KO plus Vehicle group (Additional file 2: Fig. S2).